Privacy Analytics at 2012 American Association of Clinical Oncologists Annual Meeting June 2-4, 2012

June 1, 2012 - PRLog -- Ottawa, Ont. -- Privacy Analytics Inc., the developer of the only commercially available de-identification and masking software product based on Health Insurance Portability and Accountability Act (HIPPA), will be exhibiting at the American Society of Clinical Oncology® (ASCO) Annual Meeting June 2-4, 2012, booth number 4036.  ASCO is the world’s leading professional organization representing physicians who care for people with cancer.

“Participating at ASCO is a good fit for us as many of our existing clients attend and we are able to reach out to new ones who don’t know that they can leverage their valuable health data safely under the HIPAA Privacy Rule without sacrificing granularity”, says Privacy Analytics Founder and CEO Dr. Khaled El Emam.  When releasing Personal Health Information (PHI) for secondary use, unless an organization has patient consent, it is necessary to de-identify the data and ensure that it meets the requirements in the HIPPA Privacy Rule.

“Managing people’s PHI is a big responsibility” continues Dr. El Emam.  “Historically, custodians of PHI have had difficulty releasing high utility data that is useful for research and that is also HIPAA compliant. Our products and services have made it easy to do both.”

As the developers of the only commercially available de-identification and masking software application, Privacy Analytics is in a unique position to give our clients, including researchers the ability to derive value out of their data and generate maximum granularity when conducting critical research, while protecting personal privacy. Using peer-reviewed metrics and de-identification algorithms, PARAT assesses, measures and manages re-identification risk under different scenarios of attack.

“Our clients come from a broad spectrum and range from researchers working on a single project to “big data” organizations that have hundreds of databases from which they want to pull information for secondary uses such as performance benchmarking, public competitions, surveillance, research, software testing and sales & marketing.”

ASCO ® is a registered trademark of the American Society of Clinical Oncology. ® Used with permission.  ASCO ® is not a partner or affiliate of Privacy Analytics Inc. and does not recommend or endorse any vendor, product, or service.